Welcome to our dedicated page for Intellicheck SEC filings (Ticker: IDN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Intellicheck, Inc. (Nasdaq: IDN) SEC filings page provides access to the company’s regulatory disclosures filed with the U.S. Securities and Exchange Commission. As a public issuer, Intellicheck submits annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, along with other required documents. These filings offer detailed information on the company’s identity verification business, financial condition and risk factors.
For Intellicheck, key filings include Forms 10-K and 10-Q, which present audited and unaudited financial statements, management’s discussion and analysis of results of operations, and disclosures about its SaaS-based digital and physical identity verification solutions. Current reports on Form 8-K, such as those furnished in connection with quarterly earnings press releases or investor presentations, provide timely updates on material events, financial results and corporate communications.
Investors interested in Intellicheck’s use of non-GAAP measures such as Adjusted EBITDA can review the reconciliations and explanations included in earnings-related filings and exhibits. These documents describe how management evaluates operational performance, including adjustments for items like depreciation, amortization, stock-based compensation, interest and other income, and income taxes.
Through this page, users can also locate filings that may relate to equity structure, stock-based compensation plans or other corporate actions, as disclosed in the appropriate SEC forms. Stock Titan enhances access to these documents with AI-powered summaries that highlight key points from lengthy filings, helping readers quickly understand revenue trends, operating metrics and other information that Intellicheck reports to regulators.
Intellicheck, Inc. director and CEO Bryan Lewis reported a gift and a related trust sale of company stock. He made a bona fide gift of 80,000 shares of common stock to The Lewis Family Revocable Living Trust. After this gift, he directly holds 327,126 shares.
The Lewis Family Revocable Living Trust then sold 10,000 shares of Intellicheck common stock at an average price of $7.5254 per share, leaving the trust with 70,000 shares. The trust’s sale was executed under a pre-arranged Rule 10b5-1 trading plan. Mr. Lewis disclaims beneficial ownership of the shares held by the trust.
Intellicheck, Inc. director Dondi Black received an equity grant of 715 restricted stock units that vested immediately and converted into common shares. The units were granted on March 31, 2026 at a reference price of $6.99 per share. Following this grant, Black directly holds 23,476 shares of Intellicheck common stock. This was a compensation-related award, not an open-market purchase.
Intellicheck, Inc. director Gregory Braca received 3,577 restricted stock units on March 31, 2026. The units convert to common stock on a one-for-one basis and vested in full on the grant date. Following this equity award, Braca directly holds 8,325 shares of Intellicheck common stock.
Intellicheck, Inc. director Glenn Dylan received an award of 3,577 restricted stock units on March 31, 2026. The units convert into Common Stock on a one-for-one basis and vested in full on the grant date, effectively giving him 3,577 additional shares. Following this compensation-related award, his directly held Common Stock position increased to 88,764 shares.
Intellicheck, Inc. director Guy L. Smith received an equity award of 4,292 shares of common stock through restricted stock units. The units were granted on March 31, 2026 and converted into common shares on a one-for-one basis, vesting in full on the grant date. Following this grant, Smith directly holds 423,602 shares of Intellicheck common stock. This is a compensation-related award rather than an open-market purchase.
Intellicheck, Inc. is asking stockholders to vote at its 2026 virtual annual meeting on May 7, 2026. Investors will elect six directors for one-year terms, ratify Forvis Mazars, LLP as independent public accountants for 2026, and cast advisory votes on executive pay and how often future pay votes should occur.
The proxy highlights a largely independent board, describes committee roles, details executive and director compensation, and discloses major stockholders and equity incentive plans. It also notes a clawback policy for incentive-based pay and confirms Section 16(a) reporting compliance for 2025.
The Vanguard Group filed an amended Schedule 13G/A reporting 0 shares beneficially owned of Intellicheck Inc common stock and 0% of the class. The amendment explains an internal realignment effective January 12, 2026, under SEC Release No. 34-39538 that caused certain Vanguard subsidiaries or business divisions to report ownership separately.
The filing is signed by Ashley Grim as Head of Global Fund Administration.
Intellicheck, Inc. Chief Financial Officer Adam Sragovicz received a grant of stock options as part of his compensation. He was awarded options covering 100,351 shares of Common Stock at an exercise price of $5.6000 per share, with no cash paid at grant.
All 100,351 options were newly granted and represent his entire reported option position after this transaction. According to the vesting terms, one-third of the options will vest on the first anniversary of the grant date, and the remaining two-thirds will vest quarterly over the following two years, aligning his incentives with longer-term company performance.
Intellicheck, Inc. Chief Technology Officer Jonathan Robins received a grant of stock options covering 77,000 shares of common stock. The options have an exercise price of $5.6000 per share and relate to common stock with $.001 par value.
According to the terms, one-third of the option vests on the first anniversary of the grant date, with the remaining two-thirds vesting quarterly over the following two years. The options expire on 2033-03-24, and Robins’ reported holdings after this grant are 77,000 derivative securities, held directly.
This grant is compensation-related and does not represent an open-market purchase or sale of Intellicheck shares.